CMF
TNDM icon

Counterpoint Mutual Funds’s Tandem Diabetes Care TNDM Stock Holding History

Counterpoint Mutual Funds’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,679
Closed -$243K – 382
2026
Q1 		$243K Sell
12,679
-10,179
-45% -$221K 0.04% 282
2025
Q4 		$502K Sell
22,858
-19,407
-46% -$350K 0.04% 150
2025
Q3 		$513K Buy
+42,265
New +$572K 0.04% 103
2025
Q2 		– Sell
-18,963
Closed -$363K – 439
2025
Q1 		$363K Buy
+18,963
New +$555K 0.05% 213
2023
Q4 		– Sell
-6,393
Closed -$133K – 282
2023
Q3 		$133K Buy
+6,393
New +$176K 0.11% 103

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SC
Sessa Capital New York $5.98B AUM 99.85% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
PIM
Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

Counterpoint Mutual Funds's TNDM Position: Q2 2026 in Review

Counterpoint Mutual Funds sold out of Tandem Diabetes Care (TNDM) in Q2 2026, closing a stake of 12,679 shares — an estimated $243K sold.

Counterpoint Mutual Funds first reported a position in TNDM in Q3 2023 and held it in 5 quarters. The position peaked at $513K in Q3 2025. 274 funds tracked by Wall St. Rank hold TNDM as of Q2 2026.

  • Counterpoint Mutual Funds reported no remaining Tandem Diabetes Care position as of Q2 2026 after selling out during the quarter.
  • Counterpoint Mutual Funds sold 12,679 Tandem Diabetes Care shares in Q2 2026, an estimated $243K.
  • Counterpoint Mutual Funds first reported a position in Tandem Diabetes Care in Q3 2023 and held it in 5 quarters.
  • Counterpoint Mutual Funds's Tandem Diabetes Care position peaked at $513K in Q3 2025.
  • 274 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q2 2026.

Based on Counterpoint Mutual Funds's 13F filing for Q2 2026, filed 20 Jul 2026.